German pharmaceutical giant Bayer is purchasing Schiff Nutrition International, an American vitamins maker, for $1.2 billion, Reuters reports.
According to Reuters, many pharmaceutical companies are looking to expand into non-prescription drugs. Although non-prescription drugs don’t pull in as much money as their prescription counterparts, they’re also steadier because they don’t carry risks such as clinical trial failures and patent expiries.
The story notes that some prescription medications have been causing problems for ...
continue reading...